Selected Financial Data
since 2005
Income Statement
Boston Scientific Corp., selected items from income statement, long-term trends
US$ in millions
| 12 months ended: | Net sales | Operating income (loss) | Net income (loss) |
|---|---|---|---|
| Dec 31, 2022 | 12,682) | 1,649) | 698) |
| Dec 31, 2021 | 11,888) | 1,199) | 1,041) |
| Dec 31, 2020 | 9,913) | (80) | (82) |
| Dec 31, 2019 | 10,735) | 1,518) | 4,700) |
| Dec 31, 2018 | 9,823) | 1,506) | 1,671) |
| Dec 31, 2017 | 9,048) | 1,285) | 104) |
| Dec 31, 2016 | 8,386) | 447) | 347) |
| Dec 31, 2015 | 7,477) | (327) | (239) |
| Dec 31, 2014 | 7,380) | (301) | (119) |
| Dec 31, 2013 | 7,143) | 120) | (121) |
| Dec 31, 2012 | 7,249) | (3,868) | (4,068) |
| Dec 31, 2011 | 7,622) | 904) | 441) |
| Dec 31, 2010 | 7,806) | (656) | (1,065) |
| Dec 31, 2009 | 8,188) | (894) | (1,025) |
| Dec 31, 2008 | 8,050) | (1,505) | (2,036) |
| Dec 31, 2007 | 8,357) | (14) | (495) |
| Dec 31, 2006 | 7,821) | (2,949) | (3,577) |
| Dec 31, 2005 | 6,283) | 968) | 628) |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Balance Sheet: Assets
Boston Scientific Corp., selected items from assets, long-term trends
US$ in millions
| Current assets | Total assets | |
|---|---|---|
| Dec 31, 2022 | 5,760) | 32,469) |
| Dec 31, 2021 | 6,317) | 32,229) |
| Dec 31, 2020 | 6,694) | 30,777) |
| Dec 31, 2019 | 4,699) | 30,565) |
| Dec 31, 2018 | 4,003) | 20,999) |
| Dec 31, 2017 | 3,822) | 19,042) |
| Dec 31, 2016 | 3,239) | 18,096) |
| Dec 31, 2015 | 3,471) | 18,133) |
| Dec 31, 2014 | 3,606) | 17,042) |
| Dec 31, 2013 | 3,011) | 16,571) |
| Dec 31, 2012 | 3,022) | 17,154) |
| Dec 31, 2011 | 3,105) | 21,290) |
| Dec 31, 2010 | 3,615) | 22,128) |
| Dec 31, 2009 | 4,061) | 25,177) |
| Dec 31, 2008 | 5,452) | 27,139) |
| Dec 31, 2007 | 5,921) | 31,197) |
| Dec 31, 2006 | 4,901) | 31,096) |
| Dec 31, 2005 | 2,631) | 8,196) |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Balance Sheet: Liabilities and Stockholders’ Equity
Boston Scientific Corp., selected items from liabilities and stockholders’ equity, long-term trends
US$ in millions
| Current liabilities | Total debt | Stockholders’ equity | |
|---|---|---|---|
| Dec 31, 2022 | 3,803) | 8,935) | 17,573) |
| Dec 31, 2021 | 4,274) | 9,065) | 16,622) |
| Dec 31, 2020 | 3,681) | 9,143) | 15,326) |
| Dec 31, 2019 | 4,866) | 10,008) | 13,877) |
| Dec 31, 2018 | 5,260) | 7,056) | 8,726) |
| Dec 31, 2017 | 5,654) | 5,616) | 7,012) |
| Dec 31, 2016 | 3,587) | 5,484) | 6,733) |
| Dec 31, 2015 | 2,430) | 5,677) | 6,320) |
| Dec 31, 2014 | 2,846) | 4,262) | 6,457) |
| Dec 31, 2013 | 1,824) | 4,240) | 6,539) |
| Dec 31, 2012 | 1,772) | 4,256) | 6,870) |
| Dec 31, 2011 | 1,807) | 4,261) | 11,353) |
| Dec 31, 2010 | 2,609) | 5,438) | 11,296) |
| Dec 31, 2009 | 3,022) | 5,918) | 12,301) |
| Dec 31, 2008 | 3,233) | 6,745) | 13,174) |
| Dec 31, 2007 | 3,250) | 8,189) | 15,097) |
| Dec 31, 2006 | 2,630) | 9,124) | 15,298) |
| Dec 31, 2005 | 1,479) | 2,020) | 4,282) |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Cash Flow Statement
Boston Scientific Corp., selected items from cash flow statement, long-term trends
US$ in millions
| 12 months ended: | Cash provided by operating activities | Cash (used for) provided by investing activities | Cash provided by (used for) financing activities |
|---|---|---|---|
| Dec 31, 2022 | 1,526) | (2,011) | (548) |
| Dec 31, 2021 | 1,870) | (1,597) | (95) |
| Dec 31, 2020 | 1,508) | (411) | 293) |
| Dec 31, 2019 | 1,836) | (5,041) | 2,973) |
| Dec 31, 2018 | 310) | (1,921) | 1,432) |
| Dec 31, 2017 | 1,426) | (1,010) | 110) |
| Dec 31, 2016 | 972) | (887) | (206) |
| Dec 31, 2015 | 600) | (2,186) | 1,322) |
| Dec 31, 2014 | 1,269) | (745) | (150) |
| Dec 31, 2013 | 1,082) | (475) | (596) |
| Dec 31, 2012 | 1,260) | (579) | (744) |
| Dec 31, 2011 | 1,008) | 769) | (1,721) |
| Dec 31, 2010 | 325) | (480) | (496) |
| Dec 31, 2009 | 835) | (793) | (820) |
| Dec 31, 2008 | 1,216) | 324) | (1,350) |
| Dec 31, 2007 | 934) | (474) | (680) |
| Dec 31, 2006 | 1,845) | (9,312) | 8,439) |
| Dec 31, 2005 | 903) | (551) | (954) |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Per Share Data
Boston Scientific Corp., selected data per share, long-term trends
US$
| 12 months ended: | Basic earnings per share 1 | Diluted earnings per share 2 | Dividend per share 3 |
|---|---|---|---|
| Dec 31, 2022 | 0.45 | 0.45 | 0.00 |
| Dec 31, 2021 | 0.69 | 0.69 | 0.00 |
| Dec 31, 2020 | -0.08 | -0.08 | 0.00 |
| Dec 31, 2019 | 3.38 | 3.33 | 0.00 |
| Dec 31, 2018 | 1.21 | 1.19 | 0.00 |
| Dec 31, 2017 | 0.08 | 0.08 | 0.00 |
| Dec 31, 2016 | 0.26 | 0.25 | 0.00 |
| Dec 31, 2015 | -0.18 | -0.18 | 0.00 |
| Dec 31, 2014 | -0.09 | -0.09 | 0.00 |
| Dec 31, 2013 | -0.09 | -0.09 | 0.00 |
| Dec 31, 2012 | -2.89 | -2.89 | 0.00 |
| Dec 31, 2011 | 0.29 | 0.29 | 0.00 |
| Dec 31, 2010 | -0.70 | -0.70 | 0.00 |
| Dec 31, 2009 | -0.68 | -0.68 | 0.00 |
| Dec 31, 2008 | -1.36 | -1.36 | 0.00 |
| Dec 31, 2007 | -0.33 | -0.33 | 0.00 |
| Dec 31, 2006 | -2.81 | -2.81 | 0.00 |
| Dec 31, 2005 | 0.76 | 0.75 | 0.00 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1, 2, 3 Data adjusted for splits and stock dividends.